These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39083152)

  • 1. "No One Needs to be Forced": Qualitative Insights on Competing Priorities between Antiretroviral Therapy and Reproductive Health Planning during the Dolutegravir Rollout.
    Maju M; Hassan SA; Bernard C; Maina M; Thorne JG; Komanapalli SA; Humphrey JM; Kerich C; Changwony S; Jakait B; Wools-Kaloustian K; Patel RC
    AIDS Behav; 2024 Nov; 28(11):3719-3732. PubMed ID: 39083152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contraception use and HIV outcomes among women initiating dolutegravir-containing antiretroviral therapy in Kenya: a retrospective cohort study.
    Humphrey JM; Omodi V; Bernard C; Maina M; Thorne J; Mwangi A; Wools-Kaloustian K; Patel RC
    J Int AIDS Soc; 2022 Dec; 25(12):e26046. PubMed ID: 36567432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling Study.
    Dugdale CM; Ciaranello AL; Bekker LG; Stern ME; Myer L; Wood R; Sax PE; Abrams EJ; Freedberg KA; Walensky RP
    Ann Intern Med; 2019 May; 170(9):614-625. PubMed ID: 30934067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It's only fatness, it doesn't kill": a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda.
    Alhassan Y; Twimukye A; Malaba T; Myer L; Waitt C; Lamorde M; Colbers A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Womens Health; 2022 Jun; 22(1):246. PubMed ID: 35729541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.
    Mofenson LM; Pozniak AL; Wambui J; Raizes E; Ciaranello A; Clayden P; Ehrenkranz P; Fakoya A; Hill A; Khoo S; Mahaka I; Modi S; Moore C; Phillips A; Siberry G; Sikwese K; Thorne C; Watts HD; Doherty M; Ford NP
    J Int AIDS Soc; 2019 Jul; 22(7):e25352. PubMed ID: 31298496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda.
    Twimukye A; Laker M; Odongpiny EAL; Ajok F; Onen H; Kalule I; Kajubi P; Seden K; Owarwo N; Kiragga A; Armstrong-Hough M; Katahoire A; Mujugira A; Lamorde M; Castelnuovo B
    BMC Infect Dis; 2021 Nov; 21(1):1154. PubMed ID: 34774018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational diabetes in women living with HIV in Botswana: lower rates with dolutegravir- than with efavirenz-based antiretroviral therapy.
    Mmasa KN; Powis K; Sun S; Makhema J; Mmalane M; Kgole S; Masasa G; Moyo S; Gerschenson M; Mohammed T; Legbedze J; Abrams EJ; Kurland IJ; Geffner ME; Jao J
    HIV Med; 2021 Sep; 22(8):715-722. PubMed ID: 34003565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Orrell C; Myer L; Waitt C; Lamorde M; Kambugu A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Public Health; 2020 Dec; 20(1):1883. PubMed ID: 33287795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study.
    Gedefaw A; Tadesse BT; Berhan Y; Makonnen E; Vella S; Aklillu E
    BMC Infect Dis; 2024 Sep; 24(1):901. PubMed ID: 39223552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.
    Zash R; Holmes L; Diseko M; Jacobson DL; Brummel S; Mayondi G; Isaacson A; Davey S; Mabuta J; Mmalane M; Gaolathe T; Essex M; Lockman S; Makhema J; Shapiro RL
    N Engl J Med; 2019 Aug; 381(9):827-840. PubMed ID: 31329379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda.
    Alhassan Y; Twimukye A; Malaba T; Orrell C; Myer L; Waitt C; Lamorde M; Kambugu A; Reynolds H; Khoo S; Taegtmeyer M
    BMC Health Serv Res; 2020 Aug; 20(1):705. PubMed ID: 32738918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels.
    Mohan H; Lenis MG; Laurette EY; Tejada O; Sanghvi T; Leung KY; Cahill LS; Sled JG; Delgado-Olguín P; Greene NDE; Copp AJ; Serghides L
    EBioMedicine; 2021 Jan; 63():103167. PubMed ID: 33341441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    Hauser A; Kusejko K; Johnson LF; Günthard HF; Riou J; Wandeler G; Egger M; Kouyos RD
    PLoS Med; 2020 Dec; 17(12):e1003397. PubMed ID: 33315863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum.
    Hoffman RM; Brummel S; Ziemba L; Chinula L; McCarthy K; Fairlie L; Jean-Philippe P; Chakhtoura N; Johnston B; Krotje C; Nematadzira TG; Nakayiwa F; Ndyanabangi V; Hanley S; Theron G; Violari A; João E; Correa MD; Hofer CB; Navanukroh O; Aurpibul L; Nevrekar N; Zash R; Shapiro R; Stringer JSA; Currier JS; Sax P; Lockman S;
    Clin Infect Dis; 2024 Jun; 78(6):1617-1628. PubMed ID: 38180851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.
    Pereira GFM; Kim A; Jalil EM; Fernandes Fonseca F; Shepherd BE; Veloso VG; Rick F; Ribeiro R; Pimenta MC; Beber A; Corrêa RG; Lima R; Maruri F; McGowan CC; Schwartz Benzaken A; Grinsztejn B; Castilho JL;
    Lancet HIV; 2021 Jan; 8(1):e33-e41. PubMed ID: 33387477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by Women.
    Laker EAO; Arinaitwe A; Owarwo N; Onzia A; Nasasira B; Wailagala A; Kalule I; Anguzu G; Kiragga A; Seden K; Lwanga I; Castelnuovo B; Musomba R; Lamorde M
    Drug Saf; 2020 Nov; 43(11):1133-1140. PubMed ID: 32926356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
    Kreitchmann R; Oliveira FR; Sprinz E
    Braz J Infect Dis; 2021; 25(2):101572. PubMed ID: 33852885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with uptake of contraceptives among HIV positive women on dolutegravir based anti-retroviral treatment-a cross sectional survey in urban Uganda.
    Mbabazi L; Nabaggala MS; Kiwanuka S; Kiguli J; Laker E; Kiconco A; Okoboi S; Lamorde M; Castelnuovo B
    BMC Womens Health; 2022 Jun; 22(1):262. PubMed ID: 35761248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch to dolutegravir is well tolerated in Thais with HIV infection.
    Goh OQ; Colby DJ; Pinyakorn S; Sacdalan C; Kroon E; Chan P; Chomchey N; Kanaprach R; Prueksakaew P; Suttichom D; Trichavaroj R; Spudich S; Robb ML; Phanuphak P; Phanuphak N; Ananworanich J;
    J Int AIDS Soc; 2019 Jul; 22(7):e25324. PubMed ID: 31294931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attrition from care and its predictors among women exposed to dolutegravir- and efavirenz-based first-line antiretroviral therapy in Ethiopia: a before-and-after study.
    Facha W; Tadesse T; Wolka E; Astatkie A
    Front Public Health; 2024; 12():1385441. PubMed ID: 39015389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.